BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 157853)

  • 1. Cutaneous reaction to spironolactone resembling lupus erythematosus.
    Uddin MS; Lynfield YL; Grosberg SJ; Stiefler R
    Cutis; 1979 Aug; 24(2):198-200. PubMed ID: 157853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatitis caused by aldactone of a lupic annular erythema type].
    Leroy D; Dompmartin A; Le Jean S; Guillemain JL; Mandard JC; Deschamps P
    Ann Dermatol Venereol; 1987; 114(10):1237-40. PubMed ID: 2963578
    [No Abstract]   [Full Text] [Related]  

  • 4. Bullous subacute cutaneous lupus erythematosus.
    Perera GK; Black MM; McGibbon DH
    Clin Exp Dermatol; 2004 May; 29(3):265-7. PubMed ID: 15115507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pigmented exanthema after spironolactone allergy in progressive systemic scleroderma].
    Luderschmidt C
    Dtsch Med Wochenschr; 1983 Dec; 108(50):1922-5. PubMed ID: 6228416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of systemic lupus erythematosus occurring after induced abortion and drug eruption].
    Sasaki N; Baba S; Takahashi S; Itou H; Kowada K; Shikanai T; Nakamura Y; Yamauchi K; Inoue H; Sawai T
    Arerugi; 2008 Jul; 57(7):872-7. PubMed ID: 18688188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus presenting as a bullous eruption in a child.
    Kettler AH; Bean SF; Duffy JO; Gammon WR
    Arch Dermatol; 1988 Jul; 124(7):1083-7. PubMed ID: 3291780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone-associated cutaneous effects: a case report and a review of the literature.
    Gupta AK; Knowles SR; Shear NH
    Dermatology; 1994; 189(4):402-5. PubMed ID: 7873830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset systemic lupus erythematosus with lichen planus-like eruption and cardiac tamponade.
    Koga T; Kubota Y; Kiryu H; Nakayama J; Takeda S; Kono K
    Eur J Dermatol; 2000 Dec; 10(8):620-2. PubMed ID: 11125326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus-like reaction to interferon at the injection site: report of five cases.
    Arrue I; Saiz A; Ortiz-Romero PL; Rodríguez-Peralto JL
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():18-21. PubMed ID: 17997732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of systemic lupus erythematosus and dermatopolymyositis].
    Kilani B; Amari L; Houmane H; Ben Châabane T
    Tunis Med; 2005 Apr; 83(4):230-2. PubMed ID: 15966670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bullous systemic lupus erythematosus].
    Teikemeier G; Kind P; Goerz G
    Z Hautkr; 1988 Apr; 63(4):320-5. PubMed ID: 3291441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatomyositis: a clinicopathological study of 40 patients.
    Smith ES; Hallman JR; DeLuca AM; Goldenberg G; Jorizzo JL; Sangueza OP
    Am J Dermatopathol; 2009 Feb; 31(1):61-7. PubMed ID: 19155727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular cutaneous lupus mucinosis: report of a case and review of previously reported cases.
    Kano Y; Sagawa Y; Yagita A; Nagashima M
    Cutis; 1996 Jun; 57(6):441-4. PubMed ID: 8804851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
    Schrager MA; Rothfield NF
    J Clin Invest; 1976 Jan; 57(1):212-21. PubMed ID: 1245600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.